Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$7.98 +0.15 (+1.92%)
As of: Oct 2, 2026 · 9:34 AM EDT

Eupraxia Pharmaceuticals (EPRX) Change in Cash (2023 - 2025)

Updated

Eupraxia Pharmaceuticals (EPRX) recorded Change in Cash of -$42.04 million in the quarter ended Dec 31, 2025, compared with $7.05 million a year earlier.

Analysis

Eupraxia Pharmaceuticals (EPRX) Change in Cash (2023 - 2025) Analysis & Trends

For the year ended Dec 31, 2025, Eupraxia Pharmaceuticals reported Change in Cash of $46.92 million, up 198.6% from the prior year.

  • Annual Change in Cash has a three-year compound annual growth rate of 95.9% (years ended Dec 2022 to Dec 2025).
  • Across earlier years, Change in Cash came in at $15.71 million in the year ended Dec 31, 2024, $256,970 in the year ended Dec 31, 2023 (-95.9%) and $6.24 million in the year ended Dec 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -1.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -2.82 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.49 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 739.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -2.64 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.95 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -4.45 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -727.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 649.20 Mn
10 Eupraxia Pharmaceuticals 363.60 Mn 362.00 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -42.04 Mn
Dec 31, 2024 7.05 Mn
Dec 31, 2023 -6.01 Mn
Sep 30, 2023 10.33 Mn
API Access

Eupraxia Pharmaceuticals Change in Cash API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-cash&ticker=EPRX&period=max&api_key=YOUR_API_KEY